3. Woolhandler, Steffie, and David U. Himmelstein. “Administrative Waste in the U.S. Health Care System.” Annals of Internal Medicine 172, no.2 (2020). Estimates the scale and structure of nonclinical waste.
4. Commonwealth Fund. Mirror, Mirror 2021. Comparative performance analysis of health systems across high-income countries.
5. OECD. Health at a Glance 2023. International comparisons of health spending, outcomes, and access.
6. Berwick, Donald M., Thomas W. Nolan, and John Whittington. “The Triple Aim.” Health Affairs 27, no.3 (2008). Framework linking system design to outcomes and cost.
7. Oberlander, Jonathan. The Political Life of Medicare. University of Chicago Press, 2003. History of Medicare’s expansion and political durability.
8. Blahous, Charles. Medicare for All: Issues and Challenges. Mercatus Center, 2018. Analysis of expansion pathways and fiscal mechanics.
9. Tseng, Phillip et al. “Administrative Costs in U.S. Health Care.” Health Affairs 37, no.11 (2018). Detailed breakdown of billing and insurance overhead.
10. Bodenheimer, Thomas, and Christine Sinsky. “From Triple Aim to Quadruple Aim.” Annals of Family Medicine 12, no.6 (2014). Demonstrates how primary care structure affects outcomes and clinician burnout.
11. Starfield, Barbara. “Primary Care and Health.” Milbank Quarterly 83, no.3 (2005). Landmark evidence linking primary care to population health.
12. OECD. Strengthening Primary Care Systems. OECD Publishing, 2020. Comparative policy analysis of salaried and panel-based care models.
13. Commonwealth Fund. “Primary Care Spending and Outcomes.” 2019. Empirical links between investment in primary care and system performance.
14. U.S. Government Accountability Office. Drug Pricing: Federal Investment in Drug Development. GAO-21-282, 2021. Documents public funding role in pharmaceutical R&D.
15. Kesselheim, Aaron S., et al. “The High Cost of Prescription Drugs in the United States.” JAMA 316, no.8 (2016). Analysis of pricing mechanisms and patent abuse.
16. Congressional Budget Office. Options for Reducing the Deficit: Drug Pricing. 2022. Policy levers for negotiation and reference pricing.
17. Gaynor, Martin, Kate Ho, and Robert J. Town. “The Industrial Organization of Health Care Markets.” Journal of Economic Literature 53, no.2 (2015). Evidence on consolidation and pricing power.
18. Federal Trade Commission. Policy Perspectives on Competition and Health Care. 2020. Antitrust frameworks applied to health systems.
19. Internal Revenue Service. Community Benefit Standard for Hospitals. IRS guidance and enforcement history.